Carmona-Vicente Noelia, Fernández-Jiménez Manuel, Vila-Vicent Susana, Rodríguez-Díaz Jesús, Buesa Javier
Department of Microbiology, School of Medicine, University of Valencia, Avda. Blasco Ibáñez 17, 46010, Valencia, Spain.
BMC Infect Dis. 2016 Mar 12;16:124. doi: 10.1186/s12879-016-1455-9.
Human noroviruses (NoVs) are the main cause of non-bacterial gastroenteritis worldwide. Several studies have linked human susceptibility to NoVs with the expression of histo-blood group antigens (HBGAs). In January 2012, a NoV gastroenteritis outbreak affected a household in Valencia, Spain, and the personal susceptibility to NoV was investigated.
To reach this aim 8 members of the affected household were recruited for this study and their secretor status, ABO and Lewis antigens were determined. NoV-specific saliva IgA and serum IgG antibody titers were analyzed. Their capacity to block viral binding to saliva receptors was analyzed, using virus-like particles (VLPs) of the NoV GII.4 genotype, 2006b variant, and saliva from a secretor O blood type donor.
The most relevant finding was that an asymptomatic non-secretor individual shed NoVs in his stools. Interestingly, anti-NoV IgA antibody titers in saliva from secretor and non-secretor individuals showed no differences. On the contrary, high titers of NoV-specific IgG antibody were found in both convalescent sera and in sera collected 1 year post-infection, but only from secretor individuals. NoV GII.4-2006b VLP binding to receptors present in the saliva was efficiently blocked only by sera from secretor positive individuals.
Despite the small number of individuals involved in this outbreak, this study reinforces the idea that susceptibility to human NoV is both dependent on the HBGA profile of the individuals as well as on the viral genotype and variant. We also show that the immunity to NoV lasts for at least 1 year after infection, demonstrating that symptomatic infections strongly stimulate immune responses.
人诺如病毒(NoV)是全球非细菌性肠胃炎的主要病因。多项研究已将人对NoV的易感性与组织血型抗原(HBGA)的表达联系起来。2012年1月,西班牙巴伦西亚的一个家庭发生了NoV肠胃炎疫情,并对个人对NoV的易感性进行了调查。
为实现这一目标,招募了受影响家庭的8名成员参与本研究,并确定了他们的分泌状态、ABO和Lewis抗原。分析了NoV特异性唾液IgA和血清IgG抗体滴度。使用NoV GII.4基因型2006b变体的病毒样颗粒(VLP)和分泌型O血型供体的唾液,分析了它们阻断病毒与唾液受体结合的能力。
最相关的发现是,一名无症状的非分泌型个体粪便中排出了NoV。有趣的是,分泌型和非分泌型个体唾液中的抗NoV IgA抗体滴度没有差异。相反,在恢复期血清和感染后1年采集的血清中均发现了高滴度的NoV特异性IgG抗体,但仅来自分泌型个体。NoV GII.4 - 2006b VLP与唾液中存在的受体的结合仅被分泌型阳性个体的血清有效阻断。
尽管参与此次疫情的个体数量较少,但本研究强化了这样一种观点,即人对NoV的易感性既取决于个体的HBGA谱,也取决于病毒基因型和变体。我们还表明,感染后对NoV的免疫力至少持续1年,这表明有症状感染会强烈刺激免疫反应。